David Pound - Concepedia

Author

David Pound

Indiana University – Purdue University Indianapolis

Also Known As

D C Pound, D. C. POUND, D. C. Pound, D. Pound, D.C. Pound, DAVID C. POUND, David C Pound, David C. Pound, David Pound

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Orthopaedic Research Foundation Gilead Sciences (United States)University of Miami

About

David Pound is an author at Indiana University – Purdue University Indianapolis specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	3.5K
2	Health Sciences	5	6	975
3	Public Health	1	1	15
4	Allergy	1	1	71
5	Biochemistry	1	1	61

David Pound

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy, New England Journal of Medicine	2014	1.1K
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Paul Y. Kwo, Eric Lawitz, Jonathan McCone, The Lancet HepatologyHepatitis CViral HepatitisNs3 Protease InhibitorAntiviral Drug Development	2010	703
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Douglas K. Rex, Glen A. Lehman, Thomas M. Ulbright, PubMed Epidemiology Of CancerGastroenterologyGynecologyPathologyFamily History	1993	351
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients Ira M. Jacobson, Robert S. Brown, Bradley Freilich, Hepatology	2007	306
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials Saleh A. Alqahtani, Nezam H. Afdhal, Stefan Zeuzem, Hepatology	2015	90
Flexible sigmoidoscopy plus air contrast barium enema versus colonoscopy for suspected lower gastrointestinal bleeding Douglas K. Rex, Richard A. Weddle, G A Lehman, Gastroenterology Gastrointestinal BleedingFlexible SigmoidoscopyGastroenterologyAir Contrast BariumLower Gastrointestinal Bleeding	1990	90
Transmission of Idiopathic (Autoimmune) Thrombocytopenic Purpura by Liver Transplantation Peter J. Friend, Leo J. McCarthy, Ronald S. Filo, New England Journal of Medicine ImmunologyBlood CellPathologyAutologous PlateletsImmunotherapy	1990	71
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis Steven J. Schwartz, D. Craig Brater, David Pound, Clinical Pharmacology & Therapeutics	1993	69

Page 1